Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Magnusson

Showing results (81-90 of 138) with videos related to

Pageof 14
Sort By:
Medical Biology|January 1, 1979
The inhibition of rat brain monoamine oxidase-B by J-508 (N-methyl-N-propargyl-(1-indanyl)-ammonium hydrochloride), and its use for the titration of this enzyme formC J Fowler, L Oreland, A Wiberg, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 1, 1981
The activities of monoamine oxidase-A and -B, succinate dehydrogenase and acid phosphatase in the rat brain after hemitransectionA Carlsson, C J Fowler, T Magnusson, et al.
Journal of Neural Transmission|January 1, 1976
Effect of synthetic substance P on monoaminergic mechanisms in brainT Magnusson, A Carlsson, G H Fisher, et al.
Pharmacological Reviews|June 1, 1972
Regulation of monoamine metabolism in the central nervous systemA Carlsson, W Kehr, M Lindqvist, et al.
Journal of Neural Transmission|January 1, 1984
"On-off" phenomenon in Parkinson's disease: correlation to the concentration of dopa in plasmaT Eriksson, T Magnusson, A Carlsson, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1981
Effects of hypophysectomy, adrenalectomy and (-)-propranolol on ethanol-induced decrease in plasma amino acidsT Eriksson, T Magnusson, A Carlsson, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 27, 1978
Neurotensin and its amide analogue [Gln4]-neurotensin: effects on brain monoamine turnoverJ A García-Sevilla, T Magnusson, A Carlsson, et al.
Journal of the American Chemical Society|April 29, 2004
The structure of a biosynthetic intermediate of pyrroloquinoline quinone (PQQ) and elucidation of the final step of PQQ biosynthesisOlafur T Magnusson, Hirohide Toyama, Megumi Saeki, et al.
Handbook of Experimental Pharmacology|June 23, 2011
Small molecule allosteric modulators of phosphodiesterase 4Mark E Gurney, Alex B Burgin, Olafur T Magnusson, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1988
The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slicesB M Snape, E Pileblad, A Ekman, et al.
Pageof 14

Showing results (81-90 of 138) with videos related to

Sort By:
Pageof 14
Medical Biology|January 1, 1979
The inhibition of rat brain monoamine oxidase-B by J-508 (N-methyl-N-propargyl-(1-indanyl)-ammonium hydrochloride), and its use for the titration of this enzyme formC J Fowler, L Oreland, A Wiberg, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 1, 1981
The activities of monoamine oxidase-A and -B, succinate dehydrogenase and acid phosphatase in the rat brain after hemitransectionA Carlsson, C J Fowler, T Magnusson, et al.
Journal of Neural Transmission|January 1, 1976
Effect of synthetic substance P on monoaminergic mechanisms in brainT Magnusson, A Carlsson, G H Fisher, et al.
Pharmacological Reviews|June 1, 1972
Regulation of monoamine metabolism in the central nervous systemA Carlsson, W Kehr, M Lindqvist, et al.
Journal of Neural Transmission|January 1, 1984
"On-off" phenomenon in Parkinson's disease: correlation to the concentration of dopa in plasmaT Eriksson, T Magnusson, A Carlsson, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1981
Effects of hypophysectomy, adrenalectomy and (-)-propranolol on ethanol-induced decrease in plasma amino acidsT Eriksson, T Magnusson, A Carlsson, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 27, 1978
Neurotensin and its amide analogue [Gln4]-neurotensin: effects on brain monoamine turnoverJ A García-Sevilla, T Magnusson, A Carlsson, et al.
Journal of the American Chemical Society|April 29, 2004
The structure of a biosynthetic intermediate of pyrroloquinoline quinone (PQQ) and elucidation of the final step of PQQ biosynthesisOlafur T Magnusson, Hirohide Toyama, Megumi Saeki, et al.
Handbook of Experimental Pharmacology|June 23, 2011
Small molecule allosteric modulators of phosphodiesterase 4Mark E Gurney, Alex B Burgin, Olafur T Magnusson, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1988
The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slicesB M Snape, E Pileblad, A Ekman, et al.
Pageof 14